The Significance of Low Titre Antigliadin Antibodies in the Diagnosis of Gluten Ataxia

Autor: Hadjivassiliou, Marios, Grünewald, Richard A., Sanders, David S., Zis, Panagiotis, Croall, Iain, Shanmugarajah, Priya D., Sarrigiannis, Ptolemaios G., Trott, Nick, Wild, Graeme, Hoggard, Nigel
Přispěvatelé: Zis, Panagiotis [0000-0001-8567-3092], Sarrigiannis, Ptolemaios G. [0000-0002-8380-8755], Hadjivassiliou, Marios [0000-0003-2542-8954]
Rok vydání: 2018
Předmět:
In vivo magnetic resonance spectroscopy
antigliadin antibody titre
Magnetic Resonance Spectroscopy
antigliadin antibodies
Gastroenterology
Coeliac disease
Gliadin
Serology
0302 clinical medicine
Reference Values
Cerebellum
Enteropathy
reproductive and urinary physiology
chemistry.chemical_classification
Nutrition and Dietetics
MR spectroscopy
Middle Aged
female genital diseases and pregnancy complications
030211 gastroenterology & hepatology
medicine.symptom
lcsh:Nutrition. Foods and food supply
medicine.medical_specialty
Ataxia
Glutens
education
lcsh:TX341-641
Context (language use)
Article
03 medical and health sciences
Diet
Gluten-Free

Internal medicine
medicine
Humans
Aged
Aspartic Acid
business.industry
medicine.disease
Creatine
Gluten
Diet
Immunoglobulin A
Food intolerance
body regions
Celiac Disease
chemistry
gluten sensitive enteropathy
business
030217 neurology & neurosurgery
Biomarkers
coeliac disease
Food Science
Gluten ataxia
Zdroj: Nutrients
Volume 10
Issue 10
Nutrients, Vol 10, Iss 10, p 1444 (2018)
ISSN: 2072-6643
Popis: Background: Patients with gluten ataxia (GA) without enteropathy have lower levels of antigliadin antibodies (AGA) compared to patients with coeliac disease (CD). Magnetic Resonance Spectroscopy (NAA/Cr area ratio) of the cerebellum improves in patients with GA following a strict gluten-free diet (GFD). This is associated with clinical improvement. We present our experience of the effect of a GFD in patients with ataxia and low levels of AGA antibodies measured by a commercial assay. Methods: Consecutive patients with ataxia and serum AGA levels below the positive cut-off for CD but above a re-defined cut-off in the context of GA underwent MR spectroscopy at baseline and after a GFD. Results: Twenty-one consecutive patients with GA were included. Ten were on a strict GFD with elimination of AGA, 5 were on a GFD but continued to have AGA, and 6 patients did not go on a GFD. The NAA/Cr area ratio from the cerebellar vermis increased in all patients on a strict GFD, increased in only 1 out of 5 (20%) patients on a GFD with persisting circulating AGA, and decreased in all patients not on a GFD. Conclusion: Patients with ataxia and low titres of AGA benefit from a strict GFD. The results suggest an urgent need to redefine the serological cut-off for circulating AGA in diagnosing GA.
Databáze: OpenAIRE